Aug 9, 2021 | BioForward Member News
Read the full press release here RPRD (Right Patient Right Drug) Diagnostics, a leading pharmacogenomics (PGx) test developer and services provider, today announced a Phase 1 Small Business Innovation Research (SBIR) grant (No. R43FD007247) awarded by the FDA to...
Aug 5, 2021 | BioForward Member News
Read the full press release here David O’Connor likened it to playing a game of Battleship. When new and more dangerous variants of the COVID-19 virus emerged globally in late 2020 and early 2021, scientists needed to quickly track the “hits” and “misses” of...
Aug 4, 2021 | BioForward Member News
Read the full press release here Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its...
Aug 3, 2021 | BioForward Member News
Read the full press release here The clinic has a three-fold mission: to provide a diagnosis to patients who in many cases have searched for years for an answer about what is causing their conditions, to better understand the conditions once they are identified and to...
Aug 2, 2021 | BioForward Member News
Read the full press release here A total of $750,000 in funding from the foundation over four years will establish an advanced fellowship clinical training program for early-career physicians in primary care — who are “first-contact” doctors for their patients’...